Asia Pacific Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Country: COVID-19 Impact and Growth Opportunity

Report ID: 51299 | Published Date: Sep 2024 | No. of Page: 138 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	28
2.4 Emerging Opportunities and Market Trends	31
2.5 Porter’s Fiver Forces Analysis	35
3 Segmentation of Asia Pacific Market by Vaccine Type	39
3.1 Market Overview by Vaccine Type	39
3.2 Live/Attenuated Vaccines	41
3.3 Inactivated Vaccines	42
3.4 Subunit Vaccines	43
3.5 Toxoid Vaccines	44
3.6 Conjugate Vaccines	45
3.7 Recombinant Vector Vaccines	46
3.8 Other Vaccines	47
4 Segmentation of Asia Pacific Market by Disease	48
4.1 Market Overview by Disease	48
4.2 Vaccines for Pneumococcal Disease	50
4.3 Vaccines for Poliovirus	51
4.4 Vaccines for Hepatitis	52
4.5 Vaccines for Influenza	53
4.6 Vaccines for Measles, Mumps, and Rubella (MMR)	54
4.7 Vaccines for Varicella	55
4.8 Vaccines for Human Papilloma Virus	56
4.9 Vaccines for COVID-19	57
4.10 Vaccines for Other Diseases	60
5 Segmentation of Asia Pacific Market by Administration	61
5.1 Market Overview by Administration	61
5.2 Intramuscular Route	63
5.3 Subcutaneous Route	64
5.4 Oral Route	65
5.5 Intravenous Injection	66
5.6 Other Administration Routes	67
6 Segmentation of Asia Pacific Market by Patient	68
6.1 Market Overview by Patient	68
6.2 Pediatric Vaccines	70
6.3 Adult Vaccines	72
7 Asia-Pacific Market 2020-2026 by Country	74
7.1 Overview of Asia-Pacific Market	74
7.2 China	77
7.3 Japan	80
7.4 India	84
7.5 Australia	87
7.6 South Korea	90
7.7 Rest of APAC Region	93
8 Competitive Landscape	95
8.1 Overview of Key Vendors	95
8.2 New Product Launch, Partnership, Investment, and M&A	98
8.3 Company Profiles	99
AstraZeneca plc	99
Bavarian Nordic A/S	102
China National Biotec Group Company Ltd.	105
CSL Ltd.	107
Daiichi Sankyo Co. Ltd	109
Emergent BioSolutions Inc.	111
GlaxoSmithKline plc	113
Johnson & Johnson	117
Merck & Co.	119
Moderna Inc.	121
Novavax, Inc.	122
Pfizer Inc.	124
Sanofi SA	128
Takeda Pharmaceutical Co. Ltd.	130
9 Investing in Asia Pacific Market: Risk Assessment and Management	132
9.1 Risk Evaluation of Asia Pacific Market	132
9.2 Critical Success Factors (CSFs)	135
Related Reports and Products	138
Table 1.  Snapshot of Asia Pacific Preventive Vaccines Market in Balanced Perspective, 2020-2026	17
Table 2. Growth Rate of World GDP, 2020-2022	22
Table 3.  Main Product Trends and Market Opportunities in Asia Pacific Preventive Vaccines Market	31
Table 4. Asia Pacific Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	39
Table 5. Asia Pacific Preventive Vaccines Market by Disease, 2016-2026, $ mn	48
Table 6. COVID-19 Vaccines Authorized for Emergency Use or Approved for Full Use, as of April 2021	58
Table 7. Asia Pacific Preventive Vaccines Market by Administration, 2016-2026, $ mn	61
Table 8. Asia Pacific Preventive Vaccines Market by Patient, 2016-2026, $ mn	68
Table 9. Asia Pacific Preventive Vaccines Market: Pediatric Vaccines by Disease, 2016-2026, $ mn	71
Table 10. Asia Pacific Preventive Vaccines Market: Adult Vaccines by Disease, 2016-2026, $ mn	73
Table 11. APAC Preventive Vaccines Market by Country, 2016-2026, $ mn	75
Table 12. China Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	78
Table 13. China Preventive Vaccines Market by Disease, 2016-2026, $ mn	78
Table 14. China Preventive Vaccines Market by Administration, 2016-2026, $ mn	79
Table 15. Japan Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	82
Table 16. Japan Preventive Vaccines Market by Disease, 2016-2026, $ mn	82
Table 17. Japan Preventive Vaccines Market by Administration, 2016-2026, $ mn	83
Table 18. India Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	85
Table 19. India Preventive Vaccines Market by Disease, 2016-2026, $ mn	85
Table 20. India Preventive Vaccines Market by C Administration, 2016-2026, $ mn	86
Table 21. Australia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	88
Table 22. Australia Preventive Vaccines Market by Disease, 2016-2026, $ mn	88
Table 23. Australia Preventive Vaccines Market by Administration, 2016-2026, $ mn	89
Table 24. South Korea Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	91
Table 25. South Korea Preventive Vaccines Market by Disease, 2016-2026, $ mn	91
Table 26. South Korea Preventive Vaccines Market by Administration, 2016-2026, $ mn	92
Table 27. Preventive Vaccines Market in Rest of APAC by Country, 2016-2026, $ mn	94
Table 28. AstraZeneca plc: Company Snapshot	99
Table 29. AstraZeneca plc: Revenue, 2018-2020, $ bn	100
Table 30. Bavarian Nordic A/S: Company Snapshot	102
Table 31. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020	103
Table 32. China National Biotec Group Company Ltd.: Company Snapshot	105
Table 33. CSL Ltd.: Company Snapshot	107
Table 34. Daiichi Sankyo Co. Ltd.: Company Snapshot	109
Table 35. Emergent BioSolutions Inc.: Company Snapshot	111
Table 36. GlaxoSmithKline: Company Snapshot	113
Table 37. GlaxoSmithKline: Business Segmentation	114
Table 38. GlaxoSmithKline: Product Portfolio	115
Table 39. GlaxoSmithKline: Revenue, 2018-2020, $ bn	116
Table 40. GlaxoSmithKline: Recent Developments	116
Table 41. Johnson & Johnson: Company Snapshot	117
Table 42. Johnson & Johnson: Business Segments	118
Table 43. Merck & Co., Inc.: Company Snapshot	119
Table 44. Merck & Co., Inc.: Business Segmentation	119
Table 45. Merck & Co., Inc.: Revenue, 2018-2020, $ bn	120
Table 46. Moderna Inc.: Company Snapshot	121
Table 47. Novavax, Inc.: Company Snapshot	122
Table 48. Pfizer Inc.: Company Snapshot	124
Table 49. Pfizer Inc.: Business Segmentation	125
Table 50. Pfizer Inc.: Product Portfolio	126
Table 51. Pfizer Inc.: Revenue, 2018-2020, $ bn	127
Table 52. Pfizer Inc.: Recent Developments	127
Table 53. Sanofi: Company Snapshot	128
Table 54. Sanofi: Business Segmentation	128
Table 55. Sanofi: Revenue, 2018-2020, $ bn	129
Table 56. Takeda Pharmaceutical Co. Ltd.: Company Snapshot	130
Table 57.  Risk Evaluation for Investing in Asia Pacific Market, 2020-2026	133
Table 58. Critical Success Factors and Key Takeaways	136
Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2026	16
Figure 4. Asia Pacific Preventive Vaccines Market, 2016-2026, $ mn	19
Figure 5. Development Stages of Preventive Vaccines	20
Figure 6. Impact of COVID-19 on Business	23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Preventive Vaccines Market	25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Preventive Vaccines Market	28
Figure 9. Investment Opportunity Analysis	32
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Preventive Vaccines Market	35
Figure 11. Breakdown of Asia Pacific Preventive Vaccines Market by Vaccine Type, 2020-2026, % of Revenue	40
Figure 12. Contribution to Asia Pacific 2021-2026 Cumulative Revenue by Vaccine Type, Value ($ mn) and Share (%)	40
Figure 13. Asia Pacific Preventive Vaccines Market: Live/Attenuated Vaccines, 2016-2026, $ mn	41
Figure 14. Asia Pacific Preventive Vaccines Market: Inactivated Vaccines, 2016-2026, $ mn	42
Figure 15. Asia Pacific Preventive Vaccines Market: Subunit Vaccines, 2016-2026, $ mn	43
Figure 16. Asia Pacific Preventive Vaccines Market: Toxoid Vaccines, 2016-2026, $ mn	44
Figure 17. Asia Pacific Preventive Vaccines Market: Conjugate Vaccines, 2016-2026, $ mn	45
Figure 18. Asia Pacific Preventive Vaccines Market: Recombinant Vector Vaccines, 2016-2026, $ mn	46
Figure 19. Asia Pacific Preventive Vaccines Market: Other Vaccines, 2016-2026, $ mn	47
Figure 20. Breakdown of Asia Pacific Preventive Vaccines Market by Disease, 2020-2026, % of Revenue	49
Figure 21. Contribution to Asia Pacific 2021-2026 Cumulative Revenue by Disease, Value ($ mn) and Share (%)	49
Figure 22. Asia Pacific Preventive Vaccines Market: Vaccines for Pneumococcal Disease, 2016-2026, $ mn	50
Figure 23. Asia Pacific Preventive Vaccines Market: Vaccines for Poliovirus, 2016-2026, $ mn	51
Figure 24. Asia Pacific Preventive Vaccines Market: Vaccines for Hepatitis, 2016-2026, $ mn	52
Figure 25. Asia Pacific Preventive Vaccines Market: Vaccines for Influenza, 2016-2026, $ mn	53
Figure 26. Asia Pacific Preventive Vaccines Market: Vaccines for Measles, Mumps, and Rubella (MMR), 2016-2026, $ mn	54
Figure 27. Asia Pacific Preventive Vaccines Market: Vaccines for Varicella, 2016-2026, $ mn	55
Figure 28. Asia Pacific Preventive Vaccines Market: Vaccines for Human Papilloma Virus, 2016-2026, $ mn	56
Figure 29. Asia Pacific Preventive Vaccines Market: Vaccines for COVID-19, 2016-2026, $ mn	57
Figure 30. Asia Pacific Preventive Vaccines Market: Vaccines for Other Diseases, 2016-2026, $ mn	60
Figure 31. Breakdown of Asia Pacific Preventive Vaccines Market by Administration, 2020-2026, % of Revenue	62
Figure 32. Contribution to Asia Pacific 2021-2026 Cumulative Revenue by Administration, Value ($ mn) and Share (%)	62
Figure 33. Asia Pacific Preventive Vaccines Market: Intramuscular Route, 2016-2026, $ mn	63
Figure 34. Asia Pacific Preventive Vaccines Market: Subcutaneous Route, 2016-2026, $ mn	64
Figure 35. Asia Pacific Preventive Vaccines Market: Oral Route, 2016-2026, $ mn	65
Figure 36. Asia Pacific Preventive Vaccines Market: Intravenous Injection, 2016-2026, $ mn	66
Figure 37. Asia Pacific Preventive Vaccines Market: Other Administration Routes, 2016-2026, $ mn	67
Figure 38. Breakdown of Asia Pacific Preventive Vaccines Market by Patient, 2020-2026, % of Revenue	68
Figure 39. Contribution to Asia Pacific 2021-2026 Cumulative Revenue by Patient, Value ($ mn) and Share (%)	69
Figure 40. Asia Pacific Preventive Vaccines Market: Pediatric Vaccines, 2016-2026, $ mn	70
Figure 41. Asia Pacific Preventive Vaccines Market: Adult Vaccines, 2016-2026, $ mn	72
Figure 42. Breakdown of APAC Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue	75
Figure 43. Contribution to APAC 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	76
Figure 44.  Preventive Vaccines Market in China, 2016-2026, $ mn	77
Figure 45.  Preventive Vaccines Market in Japan, 2016-2026, $ mn	81
Figure 46.  Preventive Vaccines Market in India, 2016-2026, $ mn	84
Figure 47.  Preventive Vaccines Market in Australia, 2016-2026, $ mn	87
Figure 48.  Preventive Vaccines Market in South Korea, 2016-2026, $ mn	90
Figure 49.  Preventive Vaccines Market in Rest of APAC, 2016-2026, $ mn	93
Figure 50. Growth Stage of Asia Pacific Preventive Vaccines Industry over the Forecast Period	95
Figure 51.  Top Products of AstraZeneca Based on Revenue from 2016 to 2019 (in million U.S. dollars)	100
Companies Included in Reports:
Key Players (this may not be a complete list and extra companies can be added upon request): 
AstraZeneca plc
Bavarian Nordic A/S
China National Biotec Group Company Ltd.
CSL Ltd.
Daiichi Sankyo Co. Ltd
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co.
Moderna Inc.
Novavax, Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.	
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions
Asia Pacific Preventive Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Asia Pacific Preventive Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Asia Pacific Preventive Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports